Literature DB >> 11950169

Renal pathology in hemizygous sickle cell mice.

B A Diwan1, M T Gladwin, C T Noguchi, J M Ward, A L Fitzhugh, G S Buzard.   

Abstract

Transgenic mice have been developed that express exclusively human sickle cell beta hemoglobin and have major pathological features found in humans with sickle cell disease. These mice provide a unique opportunity to investigate the fundamental mechanisms of this disease and to design new strategies to correct the associated genetic defect(s). We found that in breeding males expressing only adult human alpha-globin and sickle beta-globin (homozygous SS mice) with females containing these transgenes plus one copy of the mouse beta-globin gene (hemizygous SS mice) greater than expected numbers of hemizygous offspring were produced than homozygous mice (carrying no mouse beta-globin gene). These hemizygous mice, expressing the human alpha and sickle beta(s) transgenes in combination with mouse beta+/-, were used for our preliminary studies of their renal pathology. No kidney lesions were found in the control (129/Sv) mice, whereas about 50% of the hemizygous SS mice showed mild-to-severe kidney lesions, including glomerulonephritis, cystic atypical hyperplastic tubules, and general nephropathy. Kidneys of some hemizygous mice were normal or showed minimal nephropathy, yet those of the susceptible phenotype developed a mild-to-more-severe form of renal lesions. The tubular epithelium of kidneys of hemizygous mice of the more affected phenotype exhibited increased expression of inducible nitric oxide synthase with an increased 3-nitrotyrosine in close proximity. There was also a stronger immunostaining for vascular cell adhesion molecule-1 in the interstitial capillary cells as well as the tubular epithelial cells of the renal cortex, compared with normal control mice. The occurrence of a high incidence of renal abnormalities in our hemizygous SS mice suggests that these mice may provide a suitable model to study the pathogenesis of nephropathy resulting from altered blood flow and/or insufficient oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11950169     DOI: 10.1080/019262302753559597

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  7 in total

1.  Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.

Authors:  Claudia R Morris; Gregory J Kato; Mirjana Poljakovic; Xunde Wang; William C Blackwelder; Vandana Sachdev; Stanley L Hazen; Elliott P Vichinsky; Sidney M Morris; Mark T Gladwin
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

2.  Morphine stimulates platelet-derived growth factor receptor-β signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo.

Authors:  M L Weber; C Chen; Y Li; M Farooqui; J Nguyen; T Poonawala; R P Hebbel; K Gupta
Journal:  Br J Anaesth       Date:  2013-07-02       Impact factor: 9.166

3.  Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease.

Authors:  Elizabeth A Manci; Cheryl A Hillery; Carol A Bodian; Zheng G Zhang; Gerard A Lutty; Barry S Coller
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

4.  Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.

Authors:  Lewis L Hsu; Hunter C Champion; Sally A Campbell-Lee; Trinity J Bivalacqua; Elizabeth A Manci; Bhalchandra A Diwan; Daniel M Schimel; Audrey E Cochard; Xunde Wang; Alan N Schechter; Constance T Noguchi; Mark T Gladwin
Journal:  Blood       Date:  2007-04-01       Impact factor: 22.113

5.  Progressive glomerular and tubular damage in sickle cell trait and sickle cell anemia mouse models.

Authors:  Santosh L Saraf; Justin R Sysol; Alexandru Susma; Suman Setty; Xu Zhang; Krishnamurthy P Gudehithlu; Jose A L Arruda; Ashok K Singh; Roberto F Machado; Victor R Gordeuk
Journal:  Transl Res       Date:  2018-02-02       Impact factor: 7.012

Review 6.  The glomerulopathy of sickle cell disease.

Authors:  Kenneth I Ataga; Vimal K Derebail; David R Archer
Journal:  Am J Hematol       Date:  2014-06-19       Impact factor: 10.047

7.  Morphine promotes renal pathology in sickle mice.

Authors:  Marc L Weber; Derek Vang; Paulo E Velho; Pankaj Gupta; John T Crosson; Robert P Hebbel; Kalpna Gupta
Journal:  Int J Nephrol Renovasc Dis       Date:  2012-07-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.